Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: letrozole|DRUG: panobinostat|GENETIC: RNA analysis|GENETIC: microarray analysis|GENETIC: reverse transcriptase-polymerase chain reaction|OTHER: enzyme-linked immunosorbent assay|OTHER: immunohistochemistry staining method|OTHER: laboratory biomarker analysis
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)